from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0295c/-

LFCtreatmentdescriptionclass of inhibitor

-0.107

Amikacinug/mL Amikacintranslation

-0.299

Cap5-10ug/mL Capreomycintranslation

0.038

Rox10-50 ug/mL Roxithromycintranslation

0.401

SM2-5 ug/mL Streptomycintranslation

0.490

Tet5-10 ug/mL Tetracyclinetranslation

1.163

Rif0.2-5ug/mL Rifampicintranscription

0.387

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.566

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.838

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.477

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.887

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.408

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.608

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.175

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.740

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.632

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.324

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-2.245

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.279

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.239

Nigericin50 uM Nigericinrespiration

-0.414

TRC10-150 ug/mL Triclosanrespiration

0.238

TRZ10-25 ug/mL Thioridazinerespiration

-1.685

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.228

menadione6-10 ug/mL Menadionerespiration

-0.584

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.304

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.426

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.734

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.305

NRP_1Non-replicating persistence stage 1dosRassociated

0.177

Amp0.2mg/mL AmpicillincellWall

0.716

Cephalexin20-100 ug/mL CephalexincellWall

0.525

Cerulenin0.32-5 ug/mL CerulenincellWall

0.564

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.577

EMB10-20 ug/mL EthambutolcellWall

0.349

Eta12-40 ug/mL EthionamidecellWall

0.253

INH0.2-0.4 ug/mL IsoniazidcellWall

0.311

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.543

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.679

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.219

BZA0.12 mg/mL BenzamidearomaticAmides

0.478

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.384

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.012

H2O24 mM hydrogen peroxideDNAdamaging

-0.283

Levo10 ug/mL LevofloxacinDNAdamaging

0.291

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.056

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.485

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.437

Antimycin12.5-50 ug/mL Antimycin A?

-1.436

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.172

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.165

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.159

PA8240.2-2 ug/mL PA-824?

-1.361

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.550

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-2.826

Verapamil50 uM Verapamil?

-1.069

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.681

methoxatin10-20 ug/mL Methoxatin?